Efficacy and safety of tisotumab vedotin in previously treated recurrent or metastatic cervical cancer (innovaTV 204/GOG-3023/ENGOT-cx6): a multicentre, open-label, single-arm, phase 2 study.
暂无分享,去创建一个
B. Monk | I. Vergote | S. Pignata | R. Coleman | D. Cibula | M. Mirza | A. Laenen | L. Woelber | R. Rangwala | A. Redondo | D. Lorusso | Meng‐Yu Chen | B. Lund | S. D. Vindeløv | JeffreyR. Harris | C. Gennigens | L. Manso | F. Forget | L. Randall | Margaret Smith | L. Nicacio | A. González-Martín | M. Teng | Margaret R. Smith | Reshma A. Rangwala